Trillium Therapeutics Inc. (TRIL) Declined -5.91% or -0.32 To Price $5.17 On Friday


Trillium Therapeutics Inc. (TRIL) declined -5.91% or -0.32 to $5.17. It is about 61350 shares traded, which is 56.86% compare to the average total volume 107903. The market cap of TRIL is $69.95 million. The year to date change is -36.51%. The 52 week price range is from $4.15 to $13.3. Price of TRIL have changed -0.90% during last week. It have changed -12.00% over last month, -16.03% over last 3 months, -35.29% over last 6 months and 18.28% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TRIL is 6.01. It is 16.25% above current price. The 200-day Moving Averages for TRIL is 7.28. It is 40.81% above current price. The 52-week High is 13.3. It is 157.25% from the current price. The 52-week Low is 4.15. It is -19.73% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of TRIL is 0.89 on 2018-06-29. Short % to float is 1.03%. There are some statistics of TRIL. It is has market cap $69.95 million. The share outstanding is 13.52 million. The average volume is 107903. The percent of top 15 Institution holding is 64.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TRIL is 255.46%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TRIL is 58.99%.


Tags:

Share this post